Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Kulak Burun Bogaz Ihtisas Dergisi : KBB = Journal of Ear, Nose, and Throat|March 19, 2009
[Internal jugular vein thrombosis following functional and selective neck dissections]Necmi Arslan, Engin Dursun, Berna Oğuz, et al.
Expert Review of Vaccines|August 22, 2022
Adaptive humoral immune response and cellular immune status in cancer patients and patients under immunosuppression vaccinated against SARS-CoV-2Igor Age Kos, Maximilian Kiefer, Katharina Brill, et al.
Ejhaem|February 23, 2023
Ars2-containing bispecific, Fab- and IgG1-format BAR-bodies to target DLBCL cellsMaximilian Kiefer, Lorenz Thurner, Theresa Bock, et al.
Journal of Translational Autoimmunity|November 25, 2022
Autoantibodies against SUMO1-DHX35 in long-COVIDLorenz Thurner, Natalie Fadle, Evi Regitz, et al.
Immunology Letters|September 12, 2024
Autoantibody mediated deficiency of IL-36-receptor antagonist in a subset of patients with psoriasis and psoriatic arthritisMarie-Christin Hoffmann, Natalie Fadle, Evi Regitz, et al.
Blood|January 29, 2021
LRPAP1 autoantibodies in mantle cell lymphoma are associated with superior outcomeLorenz Thurner, Natalie Fadle, Jörg Thomas Bittenbring, et al.
Molecular Cancer|September 28, 2024
CD16+ as predictive marker for early relapse in aggressive B-NHL/DLBCL patientsSylvia Zöphel, Nadja Küchler, Johanna Jansky, et al.
Ejhaem|September 2, 2022
B-cell receptors of EBV-negative Burkitt lymphoma bind modified isoforms of autoantigensTheresa Bock, Moritz Bewarder, Onur Cetin, et al.
Haematologica|May 4, 2023
B-cell receptor reactivity against Rothia mucilaginosa in nodular lymphocyte-predominant Hodgkin lymphomaLorenz Thurner, Natalie Fadle, Evi Regitz, et al.
Blood Advances|December 8, 2025
Impact of Perforin 1 A91V germline background in patients with aggressive B-NHL treated with R-CHOPOnur Cetin, Igor Age Kos, Evi Regitz, et al.
Pageof 3